Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune responses of patients without cancer recurrence after a cancer vaccine over a long term. | Mol Clin Oncol | 2022 | 35620212 | PubTator, text mining | PubMed |
| Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer. | Front Immunol | 2022 | 35619702 | PubTator, text mining | PubMed |
| Anaerobic Hydroxyproline Degradation Involving C-N Cleavage by a Glycyl Radical Enzyme. | J Am Chem Soc | 2022 | 35611954 | PubTator, text mining | PubMed |
| Function and therapeutic development of exosomes for cancer therapy. | Arch Pharm Res | 2022 | 35604532 | PubTator, text mining | PubMed |
| Melanoma-specific antigen-associated antitumor antibody reactivity as an immune-related biomarker for targeted immunotherapies. | Commun Med (Lond) | 2022 | 35603273 | PubTator, text mining | PubMed |
| The Current Landscape of mRNA Vaccines Against Viruses and Cancer-A Mini Review. | Front Immunol | 2022 | 35603213 | PubTator, text mining | PubMed |
| mRNA-based therapeutics: powerful and versatile tools to combat diseases. | Signal Transduct Target Ther | 2022 | 35597779 | PubTator, text mining | PubMed |
| Personalized medicine: From diagnostic to adaptive. | Biomed J | 2022 | 35590431 | PubTator, text mining | PubMed |
| In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation. | Sci Rep | 2022 | 35589776 | PubTator, text mining | PubMed |
| RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System. | Clin Cancer Res | 2022 | 35583609 | PubTator, text mining | PubMed |
| Liquid biopsy in colorectal cancer: No longer young, but not yet old. | World J Gastroenterol | 2022 | 35582130 | PubTator, text mining | PubMed |
| A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. | Cancer Sci | 2022 | 35579200 | PubTator, text mining | PubMed |
| Time to evolve: predicting engineered T cell-associated toxicity with next-generation models. | J Immunother Cancer | 2022 | 35577500 | PubTator, text mining | PubMed |
| The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines. | Cancer Treat Rev | 2022 | 35576777 | PubTator, text mining | PubMed |
| Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients. | J Clin Lab Anal | 2022 | 35576501 | PubTator, text mining | PubMed |
| Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer. | Front Oncol | 2022 | 35574342 | PubTator, text mining | PubMed |
| The Era of Cytotoxic CD4 T Cells. | Front Immunol | 2022 | 35572552 | PubTator, text mining | PubMed |
| The Genetic Basis of Dormancy and Awakening in Cutaneous Metastatic Melanoma. | Cancers (Basel) | 2022 | 35565234 | PubTator, text mining | PubMed |
| The Role of T Cell Immunity in Monoclonal Gammopathy and Multiple Myeloma: From Immunopathogenesis to Novel Therapeutic Approaches. | Int J Mol Sci | 2022 | 35563634 | PubTator, text mining | PubMed |
| Consensus molecular subtype differences linking colon adenocarcinoma and obesity revealed by a cohort transcriptomic analysis. | PLoS One | 2022 | 35560039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=27